Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Colosimo ME and Katz ER | Altered prestarvation response in a nystatin resistant Dictyostelium discoideum mutant. | 2001 | Differentiation | pmid:11270118 |
| Wilson MJ et al. | A molecular epidemiological study of sequential oral isolates of Candida albicans from terminally ill patients. | 2001 | J. Oral Pathol. Med. | pmid:11302239 |
| Baca D et al. | Obstructive laryngotracheitis secondary to gentian violet exposure. | 2001 | Clin Pediatr (Phila) | pmid:11336425 |
| Santelmann H et al. | Effectiveness of nystatin in polysymptomatic patients. A randomized, double-blind trial with nystatin versus placebo in general practice. | 2001 | Fam Pract | pmid:11356731 |
| Chandra J et al. | Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. | 2001 | J. Dent. Res. | pmid:11379893 |
| Norkin LC et al. | Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. | 2001 | Exp. Cell Res. | pmid:11399051 |
| Tzatzarakis MN et al. | Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. | 2001 | J Environ Sci Health B | pmid:11411855 |
| Worthen DR et al. | Methods for the recovery and purification of polyene antifungals. | 2001 | Drug Dev Ind Pharm | pmid:11411895 |
| Boogaerts M et al. | Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. | 2001 | J. Antimicrob. Chemother. | pmid:11418517 |
| Watkinson SC | Regulation of coremium morphogenesis in Penicillium claviforme. | 1975 | J. Gen. Microbiol. | pmid:1141857 |
| Barranco R et al. | Type IV hypersensitivity to oral nystatin. | 2001 | Contact Derm. | pmid:11422284 |
| Shu M et al. | Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species. | 2001 | J. Clin. Microbiol. | pmid:11427609 |
| Chen N et al. | [Oral candidiasis in Sjögren's syndrome: prevalence, clinical features and treatment]. | 1997 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:11480009 |
| Holder IA and Neely AN | Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? Assessment by two topical antimicrobial test assay systems. | 2001 Jul-Aug | J Burn Care Rehabil | pmid:11482688 |
| Dan M | Severe vulvovaginitis associated with intravaginal nystatin therapy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11483943 |
| Mousa HA and al-Bader SM | Yeast infection of burns. | 2001 | Mycoses | pmid:11486451 |
| Colp CR and Cook WA | Successful treatment of pleural aspergillosis and bronchopleural fistula. | 1975 | Chest | pmid:1149539 |
| Patton LL et al. | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. | 2001 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:11505264 |
| Marty A and Finkelstein A | Pores formed in lipid bilayer membranes by nystatin, Differences in its one-sided and two-sided action. | 1975 | J. Gen. Physiol. | pmid:1151324 |
| Anil S et al. | Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease. | 2001 | J. Oral Pathol. Med. | pmid:11545239 |